We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.
TODAY'S HIGH
299
TODAY'S LOW
291.15
52 WEEK HIGH
414.7
52 WEEK LOW
255
% of Shares Held by
All Insider
66.65%
% of Shares Held by
Institutions
0.03%
% of Float Held by
Institutions
0.10%
Number of Institutions
Holding Shares
1
MARKET CAP
594.68 Cr.
ETERPRISE VALUE
472.51 Cr.
NO. OF SHARES
2 Cr.
BOOK VALUE
215.966
DIV. YIELD
1.5%
DEBT
2.04 Cr.
GROSS PROFIT
253.54 Cr.
CASH
115.60 Cr.
REVENUE
472.12 Cr.
REVENUE/SHARE
235.738
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | -12.52 Cr. | -43.99 Cr. | -14.35 Cr. | -6.16 Cr. |
| Change To Liabilities | 14.59 Cr. | 5.54 Cr. | 7.22 Cr. | -14.04 Lakhs |
| Total cashflows from Investing Activities | -78.08 Cr. | -64.22 Cr. | -30.88 Cr. | -18.18 Cr. |
| Net Borrowings | 1.48 Cr. | -4.55 Cr. | -28.53 Cr. | -27.67 Cr. |
| Total Cash from Financing Activities | -2.55 Cr. | -5.74 Cr. | -37.75 Cr. | -35.76 Cr. |
| Other Liabilities | 17.06 Cr. | 3.95 Cr. | -74.29 Lakhs | 3.54 Cr. |
| Total Assets | 0 | 0 | 0 | 0 |
| Net Income | 69.35 Cr. | 62.22 Cr. | 51.43 Cr. | 48.71 Cr. |
| Change in Cash | -4.50 Cr. | -70.29 Lakhs | 6.77 Cr. | -1.11 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 76.13 Cr. | 69.26 Cr. | 75.41 Cr. | 52.84 Cr. |
| Depreciation | 8.08 Cr. | 7.42 Cr. | 7.19 Cr. | 6.60 Cr. |
| Other Cashflows from Investing Activities | -8.12 Cr. | 1.61 Cr. | 1.27 Cr. | 6.51 Cr. |
| Dividends Paid | -3 Cr. | -3 Cr. | -6 Cr. | -3 Cr. |
| Change to Inventory | -26.12 Cr. | 78.35 Lakhs | -11.17 Cr. | 9.18 Cr. |
| Change to Account Receivables | -3.11 Cr. | -10.08 Cr. | 19.01 Cr. | -13.70 Cr. |
| Other Cashflows from Financing Activities | -1.03 Cr. | -1.19 Cr. | -3.22 Cr. | -5.09 Cr. |
| Change to Net Income | -3.71 Cr. | -71.84 Lakhs | 2.31 Cr. | -1.44 Cr. |
| Capital Expenditures | -45.52 Cr. | -8.75 Cr. | -7.69 Cr. | -14.93 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 95.93 Cr. | 83.72 Cr. | 67.23 Cr. | 62.19 Cr. |
| Minority Interest | 0 | 40.76 Lakhs | 38.20 Lakhs | 35.52 Lakhs |
| Net Income | 87.39 Cr. | 79.80 Cr. | 58.33 Cr. | 60.82 Cr. |
| Selling General Administrative | 70.46 Cr. | 75.66 Cr. | 73.49 Cr. | 66 Cr. |
| Gross Profit | 253.54 Cr. | 223.28 Cr. | 200.35 Cr. | 186.31 Cr. |
| Ebit | 87.39 Cr. | 79.80 Cr. | 58.33 Cr. | 60.82 Cr. |
| Operating Income | 87.39 Cr. | 79.80 Cr. | 58.33 Cr. | 60.82 Cr. |
| Other Operating Expenses | 87.59 Cr. | 60.25 Cr. | 59.11 Cr. | 52.13 Cr. |
| Interest Expense | -1.45 Cr. | -1.20 Cr. | -1.49 Cr. | -3.09 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 26.58 Cr. | 21.47 Cr. | 15.76 Cr. | 13.45 Cr. |
| Total Revenue | 472.12 Cr. | 424.18 Cr. | 386.49 Cr. | 366.14 Cr. |
| Total Operating Expenses | 384.73 Cr. | 344.38 Cr. | 328.15 Cr. | 305.32 Cr. |
| Cost of Revenue | 218.58 Cr. | 200.90 Cr. | 186.13 Cr. | 179.82 Cr. |
| Total Other Income Expense Net | 8.54 Cr. | 3.91 Cr. | 8.89 Cr. | 1.37 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 69.35 Cr. | 62.24 Cr. | 51.46 Cr. | 48.73 Cr. |
| Net Income Applicable to Common Shares | 69.35 Cr. | 62.22 Cr. | 51.43 Cr. | 48.71 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 38.27 Lakhs | 39.81 Lakhs | 36.94 Lakhs | 42.41 Lakhs |
| Capital Surplus | 0 | 64.61 Cr. | 64.61 Cr. | 64.61 Cr. |
| Total Liabilities | 101.47 Cr. | 83.67 Cr. | 75.91 Cr. | 96.28 Cr. |
| Stock Holder Equity | 432.87 Cr. | 375.29 Cr. | 313.08 Cr. | 269.34 Cr. |
| Minority Interest | 0 | 40.76 Lakhs | 38.20 Lakhs | 35.52 Lakhs |
| Other Liabilities | 16.78 Cr. | 10.52 Cr. | 6.92 Cr. | 4.32 Cr. |
| Total Assets | 534.35 Cr. | 459.37 Cr. | 389.38 Cr. | 365.98 Cr. |
| Common Stock | 20.02 Cr. | 20 Cr. | 20 Cr. | 20 Cr. |
| Retained Earnings | 0 | 290.63 Cr. | 228.45 Cr. | 184.24 Cr. |
| Other Liabilities | 10.99 Cr. | 9.98 Cr. | 9.48 Cr. | 9.25 Cr. |
| Good Will | 0 | 9.22 Cr. | 9.22 Cr. | 9.22 Cr. |
| Treasury Stock | 412.84 Cr. | 4.11 Lakhs | 2.15 Lakhs | 48.30 Lakhs |
| Other Assets | 33.57 Cr. | 31.28 Cr. | 18.54 Cr. | 18.85 Cr. |
| Cash | 18.79 Cr. | 11.43 Cr. | 12.23 Cr. | 5.45 Cr. |
| Current Liabilities | 90.48 Cr. | 73.54 Cr. | 65.58 Cr. | 85.33 Cr. |
| Long Term Asset Charges | 0 | 0 | 0 | 0 |
| Short Long Term Debt | 2.04 Cr. | 37.52 Lakhs | 39.19 Lakhs | 1.82 Cr. |
| Other Stockholder Equity | 412.84 Cr. | 4.11 Lakhs | 2.15 Lakhs | 48.30 Lakhs |
| Property Plant Equipment | 147.55 Cr. | 111.92 Cr. | 113.16 Cr. | 113.35 Cr. |
| Total Cur. Assets | 352.84 Cr. | 306.45 Cr. | 247.99 Cr. | 224.04 Cr. |
| Long Term Investments | 26 k | 8.55 Lakhs | 8.55 Lakhs | 8.55 Lakhs |
| Net Tangible Assets | 432.49 Cr. | 365.66 Cr. | 303.49 Cr. | 259.69 Cr. |
| Short Term Investments | 96.80 Cr. | 69 k | 2.44 Lakhs | 3.02 Lakhs |
| Net Receivables | 147.71 Cr. | 130.79 Cr. | 117.75 Cr. | 127.34 Cr. |
| Long Term Debt | 0 | 14.45 Lakhs | 84.89 Lakhs | 1.69 Cr. |
| Inventory | 72.74 Cr. | 46.61 Cr. | 47.39 Cr. | 36.22 Cr. |
| Accounts Payable | 71.65 Cr. | 56.79 Cr. | 51.24 Cr. | 44.01 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account